Identification of potential biomarkers for diagnosis of hepatocellular carcinoma

被引:2
|
作者
Liang, Xing-Hua [1 ]
Feng, Zheng-Ping [1 ]
Liu, Fo-Qiu [1 ]
Yan, Rong [1 ]
Yin, Liang-Yu [1 ]
Shen, Hao [1 ]
Lu, Hai-Lin [1 ]
机构
[1] Guangzhou Med Univ, Zengcheng Dist Peoples Hosp Guangzhou, Affiliated Hosp 4, Dept Gastroenterol, 1 Guangming East Rd, Guangzhou 511300, Guangdong, Peoples R China
关键词
The Cancer Genome Atlas; Gene Expression Omnibus; hepatocellular carcinoma; early diagnosis; Metascape dataset; protein-protein interaction; Kaplan-Meier Plotter; cBioPortal; GENE-EXPRESSION OMNIBUS; GTPASE-ACTIVATING PROTEIN-1; RACGAP1; EXPRESSION; POOR-PROGNOSIS; CANCER; MAPRE1; PROGRESSION; METASTASIS; HMMR;
D O I
10.3892/etm.2021.10973
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hepatocellular carcinoma (HCC) has a high mortality rate owing to its complexity. Identification of abnormally expressed genes in HCC tissues compared to those in normal liver tissues is a viable strategy for investigating the mechanisms of HCC tumorigenesis and progression as a means of developing novel treatments. A significant advantage of the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) is that the data therein were collected from different independent researchers and may be integrated, allowing for a more robust data analysis. Accordingly, in the present study, the gene expression profiles for HCC and control samples were downloaded from the GEO and TCGA. Functional enrichment analysis was performed using a Metascape dataset, and a protein-protein interaction (PPI) network was constructed using the Search Tool for the Retrieval of Interacting Genes/proteins (STRING) online database. The prognostic value of mRNA for HCC was assessed using the Kaplan-Meier Plotter, a public online tool. A gene mRNA heatmap and DNA amplification numbers were obtained from cBioPortal. A total of 2,553 upregulated genes were identified. Functional enrichment analysis revealed that these differentially expressed genes (DEGs) were mainly accumulated in metabolism of RNA and the cell cycle. Considering the complexity and heterogeneity of the molecular alterations in HCC, multiple genes for the prognostication of patients with HCC are more reliable than a single gene. Thus, the PPI network and univariate Cox regression analysis were applied to screen candidate genes (small nuclear ribonucleoprotein polypeptide B and B1, nucleoporin 37, Rac GTPase activating protein 1, kinesin family member 20A, minichromosome maintenance 10 replication initiation factor, ubiquitin conjugating enzyme E2 C and hyaluronan mediated motility receptor) that are associated with the overall survival and progression-free survival of patients with HCC. In conclusion, the present study identified a set of genes that are associated with overall survival and progression-free survival of patients with HCC, providing valuable information for the prognosis of HCC.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Identification of potential prognostic biomarkers for hepatocellular carcinoma
    Zhang, Lanyi
    Yuan, Lingyi
    Li, Dihua
    Tian, Miao
    Sun, Siyu
    Wang, Qi
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (02) : 812 - 821
  • [2] Identification reproducible microbiota biomarkers for the diagnosis of cirrhosis and hepatocellular carcinoma
    Huarong Zhang
    Junling Wu
    Yijuan Liu
    Yongbin Zeng
    Zhiyu Jiang
    Haidan Yan
    Jie Lin
    Weixin Zhou
    Qishui Ou
    Lu Ao
    AMB Express, 13
  • [3] The Identification and Analysis of MicroRNAs Combined Biomarkers for Hepatocellular Carcinoma Diagnosis
    Shi, Yi
    Men, Jingrui
    Sun, Hongliang
    Tan, Jianjun
    MEDICINAL CHEMISTRY, 2022, 18 (10) : 1073 - 1085
  • [4] Identification reproducible microbiota biomarkers for the diagnosis of cirrhosis and hepatocellular carcinoma
    Zhang, Huarong
    Wu, Junling
    Liu, Yijuan
    Zeng, Yongbin
    Jiang, Zhiyu
    Yan, Haidan
    Lin, Jie
    Zhou, Weixin
    Ou, Qishui
    Ao, Lu
    AMB EXPRESS, 2023, 13 (01)
  • [5] Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
    Hu, Xiaoyi
    Bao, Mingyang
    Huang, Jiacheng
    Zhou, Lin
    Zheng, Shusen
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [6] A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma
    Chaerkady, Raghothama
    Harsha, H. C.
    Nalli, Anuradha
    Gucek, Marjan
    Vivekanandan, Perumal
    Akhtar, Javed
    Cole, Robert N.
    Simmers, Jessica
    Schulick, Richard D.
    Singh, Sujay
    Torbenson, Michael
    Pandey, Akhilesh
    Thuluvath, Paul J.
    JOURNAL OF PROTEOME RESEARCH, 2008, 7 (10) : 4289 - 4298
  • [7] Identification of three potential biomarkers in early resectable hepatocellular carcinoma
    Ang, S.
    Wang, W.
    Soe, Y.
    Tan, C.
    Chow, W.
    Kwee, A. K.
    Toh, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Extracellular vesicles as potential biomarkers for diagnosis and recurrence detection of hepatocellular carcinoma
    Mazen A. Juratli
    Nicola S. Pollmann
    Elsie Oppermann
    Annika Mohr
    Dhruvajyoti Roy
    Andreas Schnitzbauer
    Sabine Michalik
    Thomas Vogl
    Nikolas H. Stoecklein
    Philipp Houben
    Shadi Katou
    Felix Becker
    Jens Peter Hoelzen
    Andreas Andreou
    Andreas Pascher
    Wolf O. Bechstein
    Benjamin Struecker
    Scientific Reports, 14
  • [9] Extracellular vesicles as potential biomarkers for diagnosis and recurrence detection of hepatocellular carcinoma
    Juratli, Mazen A.
    Pollmann, Nicola S.
    Oppermann, Elsie
    Mohr, Annika
    Roy, Dhruvajyoti
    Schnitzbauer, Andreas
    Michalik, Sabine
    Vogl, Thomas
    Stoecklein, Nikolas H.
    Houben, Philipp
    Katou, Shadi
    Becker, Felix
    Hoelzen, Jens Peter
    Andreou, Andreas
    Pascher, Andreas
    Bechstein, Wolf O.
    Struecker, Benjamin
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [10] Identification of lipid species: potential biomarkers for early detection of hepatocellular carcinoma
    Leung, Kit Yee
    Freitas, KayLee
    Kuang, Yu
    CLINICAL CANCER RESEARCH, 2022, 28 (17)